Compliance & Policy

EPA Clears Engineered Yeast in August 2026 TSCA New Chemical Findings

EPA cleared all new chemicals reviewed in August 2026, including an engineered Saccharomyces cerevisiae under MCAN case J-26-0002, allowing immediate commercial production under TSCA Section 5(a)(3)(C).

EPA Publishes TSCA Section 5 Statements of Findings for August 2026 New Chemical Reviews
EPA Publishes TSCA Section 5 Statements of Findings for August 2026 New Chemical ReviewsLuo Jin Hong / unsplash

Waypoints

  1. EPA cleared all August 2026 new chemical reviews as 'not likely to present an unreasonable risk' under TSCA Section 5(a)(3)(C)

  2. Case J-26-0002 covers a genetically modified Saccharomyces cerevisiae cleared via MCAN for immediate commercial fermentation

  3. Notice signed November 18, 2026; Federal Register publication November 23; docket EPA-HQ-OPPT-2026-1849

  4. Submitters must file Notice of Commencement (Form 7710-56) within 30 days of starting manufacture

  5. R&D exemption under 40 CFR 720.36 ends when academic work shifts to commercial demonstration or customer sampling

The EPA has cleared every new chemical submission it reviewed between August 1 and 31, 2026, concluding the substances and their uses are not likely to present an unreasonable risk to human health or the environment. The finding, signed November 18 by Shari Z. Barash, Director of the New Chemicals Division at the Office of Pollution Prevention and Toxics, was filed for public inspection on November 20 as Federal Register Document 2026-23789, with official publication set for November 23.

The headline case for the August cycle is J-26-0002: a genetically engineered microorganism filed under confidential business information rules and identified only by the generic name Saccharomyces cerevisiae, chromosomal integration modification. That's brewer's yeast with an engineered insert, and its clearance under a Microbial Commercial Activity Notice signals where the commercial pipeline is heading — synthetic biology and industrial fermentation.

What does the clearance actually authorize?

Under TSCA Section 5(a)(3)(C), a "not likely to present an unreasonable risk" determination lets the submitter start commercial production immediately, without burning through the remainder of the 90-day statutory review clock. For the yeast case, that means commercial culture and fermentation can begin now under the submitted parameters.

The August cycle ran across three notice types:

  • Premanufacture Notices (PMNs) under 40 CFR Part 720 — synthetic organic and inorganic chemicals and polymers
  • Microbial Commercial Activity Notices (MCANs) under 40 CFR Part 725 — intergeneric microorganisms, including case J-26-0002
  • Significant New Use Notices (SNUNs) under 40 CFR Part 721 — existing chemicals redirected toward new exposure or release pathways

All three carry a 90-day statutory timeline, and all manufacturers and importers must file at least 90 calendar days before starting non-exempt commercial activity.

Why the affirmative standard matters

This is not the old TSCA. Before the Frank R. Lautenberg Chemical Safety for the 21st Century Act of 2016, the system was passive: if EPA didn't intervene within 90 days, manufacturing proceeded by default with no federal safety finding on record. The Lautenberg amendments flipped that. EPA must now make one of three affirmative determinations on every submission, without weighing economic costs — restriction under Section 5(f) for unreasonable risk, a consent order under Section 5(e) when data are insufficient or exposure potential is substantial, or the unencumbered Section 5(a)(3)(C) clearance, which triggers the mandatory Section 5(g) publication the industry is now reading.

EPA scientists assessing these submissions evaluate molecular structures, release volumes, and occupational exposure profiles, frequently using computational modeling and toxicological read-across against structurally similar analogues. The agency also routinely pairs determinations with Significant New Use Rules, so a cleared manufacturing profile stays cleared only as long as exposure conditions don't change — later manufacturers who alter volumes or exposure pathways must file again.

Where universities lose the exemption

The compliance mechanism that keeps academic labs lawful is the R&D exemption at 40 CFR 720.36, and it has four hard conditions: the substance must be made solely for research, quantities must stay limited to experimental need, work must run under direct supervision of a technically qualified individual, and personnel must be notified of known risks through documentation, labeling, and handling procedures.

The boundary breaks when research turns commercial. Partnering with industrial sponsors, producing demonstration batches, or shipping samples to prospective customers for commercial evaluation ends the exemption. Technology transfer offices are expected to audit developmental chemistry before patent licensing or scale-up, and investigators sending novel compounds to outside collaborators must execute material transfer agreements restricting recipients to non-commercial research use.

For engineered organisms specifically, parallel provisions in 40 CFR Part 725 Subpart E define when contained research shifts into territory requiring a TSCA Experimental Release Application. Research safety professionals note that universities moving genetic constructs from Petri dishes to multi-liter fermenters face distinct operational standards — closed containment, active air filtration, and compliant waste deactivation under OSHA chemical hygiene plans.

What happens next

Cleared submitters must file EPA Form 7710-56, the Notice of Commencement, within 30 calendar days of starting non-exempt manufacture or import — that filing puts the substance on the active TSCA Inventory. The full administrative record sits in docket EPA-HQ-OPPT-2026-1849 on the federal regulations portal. The milestone to watch: whether the November 23 Federal Register publication draws SNUR proposals that lock the cleared yeast's conditions of use in place.

via casrai.org (Source)

Share this article:

More from Elena Vasquez

Elena Vasquez

Show full bio

Senior reporter covering technology and product news in Circular economy and the environmental industry at Circular Wire.

575 articles

Nearby routes

« Previous article